You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Temozolomide and radiotherapy versus radiotherapy alone in patients with glioblastoma, IDH-wildtype: post-hoc analysis of the EORTC randomized phase 3 CATNON trialCATNON: TMZ and RT vs RT alone in glioblastoma, IDH-wildtype
|
|---|---|
| Published in |
Clinical Cancer Research, March 2022
|
| DOI | 10.1158/1078-0432.ccr-21-4283 |
| Pubmed ID | |
| Authors |
C. Mircea S. Tesileanu, Marc Sanson, Wolfgang Wick, Alba A. Brandes, Paul M. Clement, Sara C. Erridge, Michael A. Vogelbaum, Anna K. Nowak, Jean-Francois Baurain, Warren P. Mason, Helen Wheeler, Olivier L. Chinot, Sanjeev Gill, Matthew Griffin, Leland Rogers, Walter Taal, Roberta Rudà, Michael Weller, Catherine McBain, Myra E. van Linde, Kenneth Aldape, Robert B. Jenkins, Johan M. Kros, Pieter Wesseling, Andreas von Deimling, Youri Hoogstrate, Iris de Heer, Peggy N. Atmodimedjo, Hendrikus Jan J. Dubbink, Rutger W.W. Brouwer, Wilfred F.J. van IJcken, Kin Jip Cheung, Vassilis Golfinopoulos, Brigitta G. Baumert, Thierry Gorlia, Pim J. French, Martin J. van den Bent |
X Demographics
The data shown below were collected from the profiles of 127 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 23 | 18% |
| United Kingdom | 10 | 8% |
| Germany | 8 | 6% |
| France | 6 | 5% |
| Spain | 6 | 5% |
| Canada | 5 | 4% |
| Italy | 4 | 3% |
| India | 4 | 3% |
| Turkey | 3 | 2% |
| Other | 17 | 13% |
| Unknown | 41 | 32% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 70 | 55% |
| Scientists | 35 | 28% |
| Practitioners (doctors, other healthcare professionals) | 17 | 13% |
| Science communicators (journalists, bloggers, editors) | 5 | 4% |
Mendeley readers
The data shown below were compiled from readership statistics for 45 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 45 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 8 | 18% |
| Researcher | 6 | 13% |
| Other | 4 | 9% |
| Student > Bachelor | 2 | 4% |
| Student > Master | 2 | 4% |
| Other | 5 | 11% |
| Unknown | 18 | 40% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 15 | 33% |
| Biochemistry, Genetics and Molecular Biology | 6 | 13% |
| Business, Management and Accounting | 1 | 2% |
| Immunology and Microbiology | 1 | 2% |
| Computer Science | 1 | 2% |
| Other | 2 | 4% |
| Unknown | 19 | 42% |
Attention Score in Context
This research output has an Altmetric Attention Score of 80. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 January 2023.
All research outputs
#548,196
of 25,872,466 outputs
Outputs from Clinical Cancer Research
#292
of 13,340 outputs
Outputs of similar age
#14,593
of 450,945 outputs
Outputs of similar age from Clinical Cancer Research
#7
of 176 outputs
Altmetric has tracked 25,872,466 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,340 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.8. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 450,945 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 176 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.